1. A method for prioritizing communication services across multiple service initiators in a multi-modal communication device, comprising:
establishing an inter-process communications link between a first processor and at least a second processor within the communication device;
responsive to a request for a first service provided by the first processor, determining whether the first service has a higher priority than a second service currently active on a second processor; and
providing a conflict message in response to the second service having a higher priority than the first service, or initiating at least one process in response to the first service having a higher priority than the second service.
2. The method of claim 1, wherein initiating at least one process comprises:
initiating the first service; and
allocating resources of the second processor to the first service.
3. The method of claim 2, further comprising:
responsive to the first service being initiated, communicating a service initiated message from the second processor to an external device.
4. The method of claim 2, further comprising:
responsive to the first service being initiated, communicating a service initiated message from the second processor to the first processor.
5. The method of claim 2, further comprising:
terminating the first service; and
responsive to the first service being terminated, communicating a service terminated message from the second processor to an external device.
6. The method of claim 2, further comprising:
terminating the first service; and
responsive to the first service being terminated, communicating a service terminated message from the second processor to the first processor.
7. The method of claim 1, further comprising:
determining whether the first service has a higher priority than a third service currently active on a first processor; and
providing a conflict message in response to the third service having a higher priority than the first service.
8. A multi-modal communication device, comprising:
a first processor;
a second processor communicatively linked to the first processor via an inter-process communications link;
wherein, responsive to a request for a first service provided by the first processor, the communication device determines whether the first service has a higher priority than a second service currently active on a second processor; and
the communication device presents a conflict message in response to the second service having a higher priority than the first service, or initiates at least one process in response to the first service having a higher priority than the second service.
9. The communication device of claim 8, wherein the process that is initiated comprises initiation of the first service and allocation of second processor resources to the first service.
10. The communication device of claim 9, wherein the communication device communicates a service initiated message from the second processor to an external device in response to the first service being initiated.
11. The communication device of claim 9, wherein the communication device communicates a service initiated message from the second processor to the first processor in response to the first service being initiated.
12. The communication device of claim 9, wherein the communication device further terminates the first service and, responsive to the first service being terminated, communicates a service terminated message from the second processor to an external device.
13. The communication device of claim 9, wherein the communication device further terminates the first service and, responsive to the first service being terminated, communicates a service terminated message from the second processor to the first processor.
14. The communication device of claim 9, wherein the communication device determines whether the first service has a higher priority than a third service currently active on a first processor and, responsive to the third service having a higher priority than the first service, provides a conflict message.
15. A machine readable storage, having stored thereon a computer program having a plurality of code sections comprising:
code for establishing an inter-process communications link between a first processor and at least a second processor within the communication device;
code for determining whether the first service has a higher priority than a second service currently active on a second processor in response to a request for a first service provided by the first processor; and
code for providing a conflict message in response to the second service having a higher priority than the first service, or initiating at least one process in response to the first service having a higher priority than the second service.
16. The machine readable storage of claim 15, wherein the code for initiating at least one process comprises code for initiating the first service.
17. The machine readable storage of claim 16, further comprising code for communicating a service initiated message from the second processor to an external device in response to the first service being initiated.
18. The machine readable storage of claim 16, further comprising code for communicating a service initiated message from the second processor to the first processor in response to the first service being initiated.
19. The machine readable storage of claim 16, further comprising:
code for terminating the first service; and
code for communicating a service terminated message from the second processor to an external device in response to the first service being terminated.
20. The machine readable storage of claim 16, further comprising:
code for terminating the first service; and
code for communicating a service terminated message from the second processor to the first processor in response to the first service being terminated.
The claims below are in addition to those above.
All refrences to claim(s) which appear below refer to the numbering after this setence.
1. A method for the treatment or prophylaxis of dermatitis, comprising administering topically to a subject in need thereof; an effective amount of a compound selected from 2-(acetyloxy)-5-hydroxybenzenehomosulfonic acid, 5-(acetyloxy)-2-hydroxybenzenechomosulfonic acid, and 2,5-bis(acetyloxy)benzenehomosulfonic acid, or a pharmaceutically acceptable salt, or solvate thereof.
2. The method of claim 1, wherein the dermatitis is selected from the group consisting of: actinic dermatitis, allergic contact dermatitis, atopic dermatitis, carcinomatous dermatitis, contact dermatitis, diaper dermatitus, stasis dermatitis, neurodermatitis, dermatomyositis and radiation-induced dermatitis.
3. The method of claim 1, further comprising administration of at least one additional therapeutic agent.
4. The method of claim 3, wherein the at least one additional therapeutic agent is selected from the group consisting of: diclofenac, T4 endonuclease, isotretinoin, acitretin cidofoir, a corticosteroid, an antibiotic, an analgesic, an immunomodulator, including oral immunomodulator such as tacrolimus and pimecrolimus, and topical immunomodulators; an immunosuppressant, an anti-angiogenic; a leukotriene modifier, and aminosalicylate, and anesthetic, a non-steroidal anti-inflammatory, a modifier of a solubilized interleukin receptor, and inhibitor of a tyrosine-kinase receptor, a protein kinase C inhibitor, and a combination of two or more thereof.
5. The method of claim 1, wherein the compound is administered at least once per week.
6. The method of claim 5, wherein the compound is administered at least once per day.
7. The method of claim 6, wherein the compound is administered at least twice per day.
8. The method of claim 1, wherein the compound is present in a pharmaceutical composition in an amount of at least about 1% ww.
9. The method of claim 8, wherein the compound is present in a pharmaceutical composition in an amount of at least about 2.5% ww.
10. The method of claim 9, wherein the compound is present in a pharmaceutical composition in an amount of at least about 5% ww.
11. The method of claim 10, wherein the compound is present in a pharmaceutical composition in an amount of at least about 10% ww.
12. The method of claim 11, wherein the compound is present in a pharmaceutical composition in an amount of at least about 15% ww.
13. The method of claim 1, wherein the compound is administered over a period of at least about one week.
14. The method of claim 13, wherein the compound is administered over a period of at least about four weeks.